The global market for artificial joints was valued at USD 16.5 billion in 2022, with an expected growth to reach USD 27.9 billion by 2032, exhibiting a revenue CAGR of 5.1% during the forecast period. The market growth is mainly attributed to the increasing geriatric population and a rise in joint-related disorders such as osteoarthritis and rheumatoid arthritis. Moreover, the market...